10/13/2025 | News release | Distributed by Public on 10/13/2025 14:19
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The FDA said Abiomed found cybersecurity vulnerabilities related to network and physical access that could be compromised and result in the product being exploited by a loss of control or having an unexpected pump stop. To date, no cyberattacks or incidents of patient harm due to the vulnerabilities have been reported. The FDA said the recall involves correcting the devices and not removing them from where they are used or sold.